DNLI
Denali Therapeutics Inc
20.40$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.7% | +37.0% | -5.0% | -3.2% | -5.5% | -7.5% | -8.3% | -9.5% | +8.5% | +10.6% | -8.5% | |
| – | -6.9% | -8.5% | -4.6% | -6.4% | -0.5% | +1.6% | +6.4% | -5.6% | +2.0% | +13.6% | -26.3% | |
| – | -14.1% | -52.3% | +23.3% | +21.4% | +93.0% | -67.5% | +148.0% | -35.6% | +125.7% | +88.8% | -48.0% | |
| – | -6.7% | -9.4% | -4.4% | -6.6% | -0.5% | -1.7% | +9.9% | -5.6% | +2.3% | +13.8% | -28.1% | |
| – | – | -44.4% | -26.3% | – | – | – | – | +35.7% | +14.6% | -26.5% | +145.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -2.1% | |
| – | +3.8% | +2.2% | -8.0% | +17.3% | +6.6% | +2.9% | -6.4% | -7.0% | +1.3% | +159.3% | -5.0% | |
| – | +9.6% | +5.9% | -9.7% | +16.9% | +17.4% | -10.1% | -0.9% | -1.0% | +9.1% | +12.0% | -18.2% | |
| – | +3.5% | +3.5% | +3.4% | +3.4% | +49.8% | -28.7% | +3.3% | +3.3% | +4.2% | +3.3% | – | |
| – | +702.3% | +25.0% | +17.6% | -31.2% | +16.1% | -24.1% | +28.2% | -37.8% | -50.6% | +1,112.6% | -70.8% | |
| – | -7.8% | +41.2% | -4.7% | -4.9% | -6.7% | -8.7% | -8.5% | -9.8% | +9.5% | -8.6% | -9.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +8.1% | +13.0% | +0.4% | +0.4% | +0.7% | +0.1% | +0.6% | +1.8% | +6.4% | +0.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.